Gene therapy for Parkinson's disease safety study
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests a new gene therapy (chemogenetics) to see if it is safe and how well it works for people with Parkinson's disease. The treatment involves a one-time infusion of a modified virus into the brain to help control movement symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 65 years old.
- You have had Parkinson's disease for at least 5 years.
- Your Parkinson's symptoms are moderate to severe when your medication wears off (Hoehn-Yahr stage 2.5 to 4).
- You regularly take levodopa or similar medication and it helps improve your movement by at least 30%.
- You are willing to postpone other brain surgeries (like deep brain stimulation) during the study unless an emergency arises.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, PDR-001, to see if it can safely remove harmful proteins from the brain in people with early Parkinson's disease. It may help slow down the disease.
This trial tests a gene therapy product called VGN-R08b for people with Parkinson's disease who have a specific genetic change (GBA1 mutation). The goal is to help improve movement and daily function.
This trial tests a new cell therapy, NouvNeu001, for people with Parkinson's disease who have had symptoms for at least 4 years and are having trouble with their current medications. The goal is to see if this treatment is safe and can improve motor symptoms that are not well controlled.
This trial tests a new stem cell treatment for people with Parkinson's disease. It's for those whose symptoms affect daily life and who still respond to levodopa but find it less effective over time.
This trial tests a new gene therapy called BBM-P002 for Parkinson's disease. It aims to see if the treatment is safe and tolerable, and may help people with moderate to advanced Parkinson's who have had the condition for at least 5 years.
This trial tests a new gene therapy called ZR001 for people with Parkinson's disease. It involves a one-time surgery to inject the therapy into the brain, and researchers want to see if it's safe and can help improve movement symptoms.
Hear when a new Gene Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.